sialosylgloboside

isolated from human teratocarcinoma cells; similar globoside proposed as marker for amyotropic lateral sclerosis; see also record for sialosylparagloboside

Also Known As:

SLLTC; sialosyl-alpha 2-3-lacto-N-neotetraosylceramide; sialosylglobotetraosylceramide; sialosyllactotetraosylceramide; Globoside I, O-(N-acetyl-alpha-neuraminosyl)-(1-3D)-

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Motor Neuron Disease (Primary Lateral Sclerosis) 01/13/1984 - "Sialosylglobotetraosylceramide: a marker for amyotropic lateral sclerosis."
2.	Colorectal Neoplasms (Colorectal Cancer) 03/28/1988 - "Biosynthesis of sialosyllactotetraosylceramide in human colorectal carcinoma cells."
3.	Carcinoma (Carcinomatosis) 03/25/1985 - "Sialosyllactotetraosylceramide, a novel ganglioside antigen detected in human carcinomas by a monoclonal antibody."

Related Drugs and Biologics

1.	Gangliosides
2.	Antigens
3.	Monoclonal Antibodies